Kailin Xu

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Multiple myeloma1 trial

Phase

• Phase 1/22 trials

Status

• Recruiting2 trials

Lead sponsor

• Xuzhou Medical University2 trials

Running trials

• Recruiting

  Safety and Efficacy of APRIL-BAFF-Bicephali CAR-T in Relapsed, Refractory Multiple Myeloma

  NCT06132711· Phase 1/2· Xuzhou Medical University· Source

  Contact: Kailin Xu, M.D., Ph.D.

• Recruiting

  Administration of Anti Tim-3/CD123 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)

  NCT06125652· Phase 1/2· Xuzhou Medical University· Source

  Contact: Kailin Xu, M.D., Ph.D.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting
• Multiple myeloma1 recruiting